MARKET

BCDA

BCDA

Biocardia Inc
NASDAQ
0.4070
-0.0121
-2.89%
After Hours: 0.4070 0 0.00% 17:52 03/28 EDT
OPEN
0.3900
PREV CLOSE
0.4191
HIGH
0.4150
LOW
0.3900
VOLUME
293.67K
TURNOVER
0
52 WEEK HIGH
2.920
52 WEEK LOW
0.3600
MARKET CAP
10.55M
P/E (TTM)
-0.6502
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BCDA last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at BCDA last week (0311-0315)?
Weekly Report · 03/18 11:23
Weekly Report: what happened at BCDA last week (0304-0308)?
Weekly Report · 03/11 11:20
Weekly Report: what happened at BCDA last week (0226-0301)?
Weekly Report · 03/04 11:23
Weekly Report: what happened at BCDA last week (0219-0223)?
Weekly Report · 02/26 11:37
Weekly Report: what happened at BCDA last week (0212-0216)?
Weekly Report · 02/19 11:39
Weekly Report: what happened at BCDA last week (0205-0209)?
Weekly Report · 02/12 11:28
Weekly Report: what happened at BCDA last week (0129-0202)?
Weekly Report · 02/05 11:37
More
About BCDA
BioCardia, Inc. is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases. It is advancing two cell therapy platforms derived from bone marrow such as CardiAMP autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI); and neurokinin-1 receptor positive (NK1R+) allogeneic mesenchymal stem cell (MSC) therapy platform is being advanced for two clinical indications: the treatment of ischemic HFrEF and acute respiratory distress syndrome (ARDS). Its autologous CardiAMP and allogeneic NK1R+ cell therapies intended for cardiac indications of HFrEF and CMI are enabled by its Helix minimally invasive intramyocardial therapeutic delivery platform. Helix delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart.

Webull offers BioCardia Inc stock information, including NASDAQ: BCDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCDA stock methods without spending real money on the virtual paper trading platform.